LYVGEN BIOPHARMA CO., LTD.

City:

Shanghai

Country:

China

Published Applications:

Last publication date:

2022-03-17

Patent Grants:

Last grant date:

2021-11-30

Top Inventors for applications by LYVGEN BIOPHARMA CO., LTD.

These are the the leading inventors for applications assigned to LYVGEN BIOPHARMA CO., LTD.:

Yi Wu 4 Shanghai, China
Jieyi Wang 4 Belmont, CA United States
Li Wu 1 Shanghai, China

Recent patent applications by LYVGEN BIOPHARMA CO., LTD.

LYVGEN BIOPHARMA CO., LTD. based in Shanghai, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-03-17

US20220081487A1

Chemistry; metallurgy

ANTI-CD40 BINDING MOLECULES HAVING ENGINEERED FC DOMAINS AND THERAPEUTIC USES THEREOF

#2 | 2021-09-30 ✅ Patent 11,186,648 granted on 2021-11-30

US20210301029A1

Chemistry; metallurgy

Anti-CD40 antibody having engineered Fc domains and therapeutic uses thereof

#3 | 2021-08-12 ✅ Patent 11,203,643 granted on 2021-12-21

US20210246218A1

Chemistry; metallurgy

Humanized anti-CD137 antibodies and uses thereof

#4 | 2020-12-10 ✅ Patent 11,505,615 granted on 2022-11-22

US20200385479A1

Chemistry; metallurgy

Anti-CD137 antibodies and uses thereof

Also check out LYVGEN BIOPHARMA CO., LTD.'s (Shanghai, China) applicant profile with 1 patent applications submitted.

AssigneeID:

166319 ⎘